SAN JOSE, California, July 13 --
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control
solutions for biologics applications today announced a development agreement
with Biogen Idec, Inc. (Nasdaq: BIIB) aimed at evaluating emerging technologies
for single-use bioprocessing. These technologies include novel disposable
sensors, software platforms, and control algorithms.
As part of the agreement, Finesse will provide prototype sensors, software, and
systems for use by Biogen Idec in its bioprocessing platforms, and refine them
for single-use applications. This collaboration allows state-of-the art
technologies to be honed in actual use-case scenarios, and will leverage the
expertise of both companies.
Dr. Mark Selker, Chief Technology Officer and founder of Finesse, stated, We
are delighted to have the efforts of world-class scientists at Biogen Idec help
refine our technologies and focus our development. This will go far in helping
to optimize our products using actual cell culture platforms.
Dr. Thomas Ryll, Director Bioprocess Development at Biogen Idec, said, We are
excited about the opportunity to work with Finesse on testing and improving new
sensor technology for use in our high productivity process platforms.
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new
measurement and control technologies, in order to enable the transition to
single-use systems, bring new capabilities to existing bioreactor platforms, and
harmonize global bio-process information transfer. Our current product family
provides comprehensive measurement and control solutions for upstream processes
in the biotech and pharmaceutical industries. For more information, please visit
us at www.finesse.com.
SOURCE: Finesse Solutions, LLC
Barbara Paldus, +1-408-570-9011, for Finesse Solutions, LLC